Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-059634

President and CEO acquired 2,470 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mack David Henry President and CEO 2020-11-18 Option exercise +2,470 $0.53 $1,309 2,470 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mack David Henry President and CEO 2020-11-18 Option exercise · Stock Option (right to buy) −2,470 492,867 D: show line 2 in the form
Loading xslF345X03/doc4.xml…